Correlation Engine 2.0
Clear Search sequence regions

  • cells (1)
  • gene (1)
  • hippocampus (1)
  • homeostasis (1)
  • MIRN134 (1)
  • mirna (1)
  • mirna (4)
  • phase (2)
  • protein rat (1)
  • Pumilio 2 (4)
  • rats (3)
  • receptors ampa (2)
  • rna (4)
  • subunits (1)
  • synapses (3)
  • Sizes of these terms reflect their relevance to your search.

    Neurons employ a set of homeostatic plasticity mechanisms to counterbalance altered levels of network activity. The molecular mechanisms underlying homeostatic plasticity in response to increased network excitability are still poorly understood. Here, we describe a sequential homeostatic synaptic depression mechanism in primary hippocampal neurons involving miRNA-dependent translational regulation. This mechanism consists of an initial phase of synapse elimination followed by a reinforcing phase of synaptic downscaling. The activity-regulated microRNA miR-134 is necessary for both synapse elimination and the structural rearrangements leading to synaptic downscaling. Results from miR-134 inhibition further uncover a differential requirement for GluA1/2 subunits for the functional expression of homeostatic synaptic depression. Downregulation of the miR-134 target Pumilio-2 in response to chronic activity, which selectively occurs in the synapto-dendritic compartment, is required for miR-134-mediated homeostatic synaptic depression. We further identified polo-like kinase 2 (Plk2) as a novel target of Pumilio-2 involved in the control of GluA2 surface expression. In summary, we have described a novel pathway of homeostatic plasticity that stabilizes neuronal circuits in response to increased network activity. © 2014 The Authors.


    Roberto Fiore, Marek Rajman, Chrysovalandis Schwale, Silvia Bicker, Anna Antoniou, Claus Bruehl, Andreas Draguhn, Gerhard Schratt. MiR-134-dependent regulation of Pumilio-2 is necessary for homeostatic synaptic depression. The EMBO journal. 2014 Oct 1;33(19):2231-46

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 25097251

    View Full Text